COMMUNIQUÉS West-GlobeNewswire

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts
20/05/2025
Vancouver, Canada, May 20, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Promex Industries CEO Richard Otte Honored with IEEE Electronics Manufacturing Technology Award
20/05/2025
Award Recognizing Numerous Contributions to Be Presented at ECTC 2025 SANTA CLARA, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Promex Industries, Inc. , a Silicon Valley-based provider of advanced design, packaging, and [...]
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
20/05/2025
Southlake, TX, May 20, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc . (Nasdaq:HSCS) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs [...]
Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
20/05/2025
– Rademikibart significantly improved airway function, as measured by FEV 1 , within a day and significantly reduced acute exacerbations in patients with inflammation-mediated chronic asthma strongly supporting ongoing [...]
Longeveron® to Attend BIO International Convention 2025
20/05/2025
Focus on potential partnership and strategic opportunities for the Company’s stem cell therapy program for Alzheimer’s disease Recent Type B meeting with FDA provided alignment on a planned single, pivotal Phase 2/3 [...]
Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities
20/05/2025
Singapore, May 20, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”) , today announced that its subsidiary has been awarded a significant contract worth S$375 million by Pancare Technology [...]
Easy Environmental Solutions Advances African Fertilizer Expansion Following High Level Meetings in Qatar
20/05/2025
DOHA, Qatar, May 20, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), now doing business as Easy Environmental Solutions Inc . , is proud to announce a recently held high-level meeting with leaders [...]
4D Path Expands Scientific Advisory Board with Global Leaders in Oncology and Pathology
20/05/2025
Renowned experts join forces to accelerate the impact of digital treatment prediction biomarkers NEWTON, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- 4D Path , a company dedicated to personalizing cancer care through its [...]
PTPN Celebrates 40 Years of Empowering Private Practice Therapists Nationwide
20/05/2025
Innovative Network Continues to Support Physical, Occupational and Speech Therapists in a Changing Healthcare Landscape LOUISVILLE, Ky., May 20, 2025 (GLOBE NEWSWIRE) -- PTPN , the nation's first specialty network for [...]
Founder of Pfeifer Aesthetic Plastic Surgery Appointed President of The Aesthetic Society
20/05/2025
New York, NY, May 20, 2025 (GLOBE NEWSWIRE) -- Pfeifer Aesthetic Plastic Surgery proudly announces that its founder, Dr. Tracy M. Pfeifer , has been appointed as the 2025 President of The American Society for Aesthetic [...]
Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic
20/05/2025
The program, licensed exclusively to BMS, represents the third ADC candidate using the company’s proprietary Tubutecan technology to reach the clinic. MUNICH, GERMANY, May 20, 2025 – Tubulis today announced that the [...]
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site
20/05/2025
USC Spine Center, part of Keck Medicine of USC, specializes in treating complex spine conditions with the latest cutting-edge technologies CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s [...]
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
20/05/2025
Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC Antibody Formats Towards Clinical Studies VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and [...]
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
20/05/2025
Allschwil, Switzerland, May 20, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections [...]
CROSSJECT prépare le lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant d’environ 5 millions d’euros en préparation des activités commerciales et de production liées à l’approbation EUA
20/05/2025
Communiqué de presse CROSSJECT prépare le lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant d’environ 5 millions d’euros en préparation des activités commerciales [...]
CROSSJECT prepares for the launch of a capital increase with preferential subscription rights of around 5 million euros in preparation for commercial and production activities linked to EUA approval
20/05/2025
Press Release CROSSJECT prepares for the launch of a capital increase with preferential subscription rights of around 5 million euros in preparation for commercial and production activities linked to EUA approval The [...]
AB Science annonce le succès d'un placement privé de 1,8 millions d'euros
20/05/2025
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE D’ENVIRON 1,8 MILLION D’EUROS Paris, 20 mai 2025, 8h AB Science S.A. (la “ Société ” ou “ AB Science ”, Euronext – FR0010557264 – AB) annonce [...]
AB Science announces the successful completion of a EUR 1.8 million private placement
20/05/2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.8 MILLION PRIVATE PLACEMENT Paris, May 20, 2025, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces [...]
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer
20/05/2025
These results indicate that EXACT Therapeutics’ Acoustic Cluster Therapy (ACT ® ) significantly enhances the local effect of chemotherapy In the patients who had a response to chemotherapy, ACT-treated tumours showed a [...]

Pages